Journal Article Review Epublish 94 citations
PubMed: 36530909 DOI: 10.3389/fmed.2022.995044
Immune modulation after traumatic brain injury.
Front Med (Lausanne) 9:995044
Authors: Marwan Bouras, Karim Asehnoune, Antoine Roquilly
Affiliations
- Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
- CHU Nantes, INSERM, Nantes Université, Anesthesie Reanimation, CIC 1413, Nantes, France.
Abstract
Traumatic brain injury (TBI) induces instant activation of innate immunity in brain tissue, followed by a systematization of the inflammatory response. The subsequent response, evolved to limit an overwhelming systemic inflammatory response and to induce healing, involves the autonomic nervous system, hormonal systems, and the regulation of immune cells. This physiological response induces an immunosuppression and tolerance state that promotes to the occurrence of secondary infections. This review describes the immunological consequences of TBI and highlights potential novel therapeutic approaches using immune modulation to restore homeostasis between the nervous system and innate immunity.
MeSH
Nervous System, Immunosuppression Therapy, Immunomodulation, Immunity, Innate, Brain Injuries, Traumatic
Cited by
- Immunity in neuromodulation: probing neural and immune pathways in brain disorders. J Neuroinflammation, 2025
- The Immune Response in Two Models of Traumatic Injury of the Immature Brain. Cells, 2024
- Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders. Biomedicines, 2023
- Traumatic Brain Injury and Dementia: Mechanisms, Risk Stratification, and Clinical Management. J Clin Neurol, 2025
- Lymphocyte Subset Imbalance in Cardiometabolic Diseases: Are T Cells the Missing Link? Int J Mol Sci, 2025
- Backpack-mediated anti-inflammatory macrophage cell therapy for the treatment of traumatic brain injury. PNAS Nexus, 2024
- Targeting the AKT-P53/CREB pathway with epicatechin for improved prognosis of traumatic brain injury. CNS Neurosci Ther, 2024
- The emerging importance of skull-brain interactions in traumatic brain injury. Front Immunol, 2024
- Pulmonary Effects of Traumatic Brain Injury in Mice: A Gene Set Enrichment Analysis. Int J Mol Sci, 2024
- Immune Response in Traumatic Brain Injury. Curr Neurol Neurosci Rep, 2024
- Dietary Intake of n-3 Polyunsaturated Fatty Acids Prior to a Mild Traumatic Brain Injury Demonstrates a Dose-Response Effect for Neuroprotective Benefits in Male C57BL/6 Mice. Curr Dev Nutr, 2025
- Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR/AKT/STAT pathway. Sci Rep, 2023
- The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years? Cereb Circ Cogn Behav, 2024
- Elucidating the neuroimmunology of traumatic brain injury: methodological approaches to unravel intercellular communication and function. Front Cell Neurosci, 2024
- Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 1: their emergence from injuries to the donor organ. Front Transplant, 2025
- Astroglial Cells: Emerging Therapeutic Targets in the Management of Traumatic Brain Injury. Cells, 2024
- Exploring Molecular Pathways in Exercise-Induced Recovery from Traumatic Brain Injury. Med Sci Monit, 2025
- Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies. Pharmaceuticals (Basel), 2025